DHL Survey on Generative AI for MyChart Messaging
Duke Health Listens Survey on Generative Artificial Intelligence (AI) for MyChart Messaging
1 other identifier
interventional
1,454
1 country
1
Brief Summary
The purpose of this study is to understand how patients feel about the use of computer programs to create responses when they send electronic messages to their doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2023
CompletedStudy Start
First participant enrolled
October 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2023
CompletedDecember 13, 2023
October 1, 2023
1 month
October 23, 2023
December 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient satisfaction, as measured by survey
Likert-scale responses to satisfaction question: "I am satisfied with this interaction", on a scale from 1-5 with answer options of Strongly Disagree (1), Disagree (2), Neither agree nor disagree (3), Agree (4), and Strongly agree (5).
Up to 2 weeks
Patient attitudes towards utility, as measured by survey
Likert-scale responses to utility question: "The information is useful", on a scale from 1-5 with answer options of Strongly Disagree (1), Disagree (2), Neither agree nor disagree (3), Agree (4), and Strongly agree (5).
Up to 2 weeks
Patient empathy, as measured by survey
Likert-scale responses to empathy question: "I feel cared for during this interaction", on a scale from 1-5 with answer options of Strongly Disagree (1), Disagree (2), Neither agree nor disagree (3), Agree (4), and Strongly agree (5).
Up to 2 weeks
Study Arms (6)
Arm A
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm A receives AHN in Send 1, BAIC in Send 2, and CHH in Send 3
Arm B
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm B receives BHC in Send 1, CAIH in Send 2, and AAIN in Send 3
Arm C
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm C receives CHC in Send 1, AHH in Send 2, and BAIN in Send 3
Arm D
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm D receives AAIH in Send 1, BHN in Send 2, and CAIC in Send 3
Arm E
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm E receives BAIH in Send 1, CHN in Send 2, and AHC in Send 3
Arm F
OTHEREach arm will receive 3 clinical scenarios spaced over time across 3 Sends. The 6 groups (Arms A-F) will be arranged with naming conventions as such: * First letter = A, B, or C where A = scenario 1, B = scenario 2, and C = scenario 3. * Second letter(s) = H or AI, where H = human response and AI = AI-written response to the patient question posed. * Third letter(s) = N, C, or H, where N = no disclosure, C = computer disclosure, and H = human disclosure. This refers to the disclosure at the bottom of the response message whereby the author is or is not disclosed. Arm F receives CAIN in Send 1, AAIC in Send 2, and BHH in Send 3
Interventions
We will use a large language model such as GPT 3.5 to automatically generate responses to fictional messages to a physician. We will disclose whether the message was generated using this technology or not. There are 3 clinical scenarios and 6 pairs of human/AI response and human disclosure/AI disclosure/not disclosed that will test patient attitudes toward this technology.
Eligibility Criteria
You may qualify if:
- Member of the Duke Health Listens patient advocacy community
You may not qualify if:
- Age \< 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27710, United States
Related Publications (1)
Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB, Faix DJ, Goodman AM, Longhurst CA, Hogarth M, Smith DM. Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum. JAMA Intern Med. 2023 Jun 1;183(6):589-596. doi: 10.1001/jamainternmed.2023.1838.
PMID: 37115527BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anand Chowdhury, MD, MMCi
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not be aware of the arm they are assigned to. There is no care provider or outcomes assessor in this study, as the patients will report their own perceptions in a survey.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2023
First Posted
October 30, 2023
Study Start
October 31, 2023
Primary Completion
December 11, 2023
Study Completion
December 11, 2023
Last Updated
December 13, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share
The investigators will not collect individual patient identifiers, and aggregate data will be reported